Clinical Trials Logo
  1. Home
  2. Palmoplantar Pustulosis
  3. NCT05174065

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Palmoplantar Pustulosis Clinical Trial

Official title:
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Apremilast (AMG 407) in Japanese Subjects With Palmoplantar Pustulosis (PPP)

Clinical Trial Summary

The primary objective of the study is to evaluate the efficacy of apremilast (AMG 407) twice daily (BID) compared with placebo in participants with Palmoplantar Pustulosis (PPP).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05174065
Study type Interventional
Source Amgen
Contact
Status Active, not recruiting
Phase Phase 3
Start date March 8, 2022
Completion date June 6, 2024
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04493424 - A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab Phase 2
Recruiting NCT05994976 - Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Completed NCT04572997 - Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS) Phase 2
Completed NCT03633396 - A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis Phase 2
Active, not recruiting NCT04459507 - A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan
Completed NCT01780857 - Immune Signature of Palmoplantar Pustulosis N/A
Completed NCT03972280 - Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis Phase 1
Completed NCT01794117 - Anakinra for Inflammatory Pustular Skin Diseases Phase 2
Recruiting NCT05710185 - Deucravacitinib for the Treatment of Palmoplantar Pustulosis Phase 4
Terminated NCT05194839 - A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) Phase 2
Active, not recruiting NCT04566471 - Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence
Completed NCT03988335 - A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) Phase 2
Completed NCT02641730 - An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis Phase 3
Completed NCT04061252 - A Study of KHK4827 in Subjects With Palmoplantar Pustulosis Phase 3